OncoResponse

0 followers


OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

Clifford J. Stocks
Chief Executive Officer

Clifford J. Stocks

Collapse
Chris Russell
Chief Financial Officer
Kamal D. Puri
Chief Scientific Officer
Larry Stark
VP, Information Technology
Myriam Bouchlaka
Director Immuno-Oncology
Peter Probst
Senior Director Immuno-Oncology
Stephen Willingham
Senior Director/Head of Translational Medicine
Tiffany F.
Associate Director, CMC